scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10571-005-4939-5 |
P698 | PubMed publication ID | 16133942 |
P50 | author | Diogo O Souza | Q39272593 |
P2093 | author name string | Fábio Duarte Schwalm | |
Félix Antunes Soares | |||
Juliana Karl Frizzo | |||
Marcos Emílio Frizzo | |||
P2860 | cites work | Astrocyte glutamate transport: review of properties, regulation, and physiological functions | Q28138001 |
Glutamate as a neurotransmitter in the brain: review of physiology and pathology | Q28139934 | ||
Glutamate uptake | Q28190140 | ||
Glutamate release and neuronal damage in ischemia | Q28207150 | ||
A simplification of the protein assay method of Lowry et al. which is more generally applicable | Q29615220 | ||
Glutamatergic neurotransmission in aging: a critical perspective. | Q31863146 | ||
The changing landscape of ischaemic brain injury mechanisms. | Q33678157 | ||
Separate mechanisms for short- and long-term memory | Q33727445 | ||
Glutamate receptors and transporters in genetic and acquired models of epilepsy | Q33748786 | ||
Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex | Q35125588 | ||
Glutamate transporters: animal models to neurologic disease | Q35729357 | ||
Bioenergetics and glutamate excitotoxicity | Q41114102 | ||
Role of adenosine as a modulator of synaptic activity in the central nervous system | Q41478113 | ||
Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. | Q41704307 | ||
Glutamate receptors in the mammalian central nervous system | Q41742131 | ||
Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine | Q42464887 | ||
Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia | Q42466571 | ||
Activation of glutamate uptake by guanosine in primary astrocyte cultures. | Q43558663 | ||
Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. | Q43726002 | ||
Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions | Q44241104 | ||
Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake | Q44413919 | ||
Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice | Q44466849 | ||
Anticonvulsant effect of GMP depends on its conversion to guanosine. | Q44814268 | ||
Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats. | Q45159502 | ||
Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice | Q46366822 | ||
Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes | Q48827823 | ||
The neuroprotective agent MS-153 stimulates glutamate uptake | Q48902286 | ||
Sustained depolarisation induces changes in the extracellular concentrations of purine and pyrimidine nucleosides in the rat thalamus. | Q51404981 | ||
Neurochemical analysis of focal ischemia in rats | Q67705253 | ||
Nicergoline enhances glutamate re-uptake and protects against brain damage in rat global brain ischemia | Q73264238 | ||
Guanosine and GMP prevent seizures induced by quinolinic acid in mice | Q73740298 | ||
Substrate-induced up-regulation of Na(+)-dependent glutamate transport activity | Q73795075 | ||
P433 | issue | 5 | |
P304 | page(s) | 913-921 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | Cellular and Molecular Neurobiology | Q2333197 |
P1476 | title | Guanosine enhances glutamate transport capacity in brain cortical slices | |
P478 | volume | 25 |
Q39991264 | A purine-selective nucleobase/nucleoside transporter in PK15NTD cells |
Q26996723 | Current approaches to enhance glutamate transporter function and expression |
Q35777621 | Effects of 3 weeks GMP oral administration on glutamatergic parameters in mice neocortex. |
Q45325730 | Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion. |
Q30502426 | Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice |
Q62267121 | Neuroprotective Agents: Is Effective on Toxicity in Glial Cells? |
Q36966650 | Neuroprotective Effects of the Glutamate Transporter Activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat. |
Q54581993 | Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition. |
Q93142905 | Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model |
Q95643364 | Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators |
Q26744633 | The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation |
Q48970988 | The antidepressant-like effect of chronic guanosine treatment is associated with increased hippocampal neuronal differentiation |